skip to main content

AED manufacturer switching — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDispensingAED manufacturer switchingGPhC CRA

A 42-year-old man with epilepsy well-controlled on lamotrigine 200 mg twice daily presents with a prescription for lamotrigine from a different manufacturer than he usually receives. He asks if it matters. What is the most appropriate advice?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BLamotrigine is a Category 1 anti-epileptic and the same manufacturer's product should be maintained where possible

The MHRA classifies anti-epileptic drugs into three categories based on the clinical significance of switching between different manufacturers' products. Lamotrigine is Category 1, meaning the same manufacturer's product should be dispensed consistently to avoid variability in plasma levels and potential loss of seizure control. If a switch is unavoidable, increased clinical monitoring is recommended.

Reference: MHRA Drug Safety Update; BNF